KRANE FUNDS ADVISORS LLC – Gilead Sciences, Inc. Transaction History
KRANE FUNDS ADVISORS LLC portfolio value:
$460,000
portfolio value
KRANE FUNDS ADVISORS LLC quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -2.25% | -172 shares | -12K | $61.69 | 7.45K |
Q2 2022 | share | Decrease | -11.79% | -1.02K shares | -42K | $61.81 | 7.62K |
Q1 2022 | share | Increase | +17.72% | 1.30K shares | -19K | $59.45 | 8.64K |
Q4 2021 | share | Decrease | -4.99% | -386 shares | -7K | $73.36 | 7.34K |
Q3 2021 | share | Decrease | -8.94% | -759 shares | -45K | $69.85 | 7.73K |
Q2 2021 | share | Increase | +33.38% | 2.12K shares | 174K | $68.17 | 8.49K |
Q1 2021 | share | Increase | +44.18% | 1.95K shares | 154K | $63.33 | 6.36K |
Q4 2020 | share | Increase | 0.00% | 4.41K shares | 257K | $56.43 | 4.41K |